2Seventy Gross Profit from 2010 to 2025

TSVT Stock  USD 4.96  0.01  0.20%   
2Seventy Bio Gross Profit yearly trend continues to be comparatively stable with very little volatility. Gross Profit is likely to outpace its year average in 2025. Gross Profit is the profit 2Seventy Bio makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals
 
Gross Profit  
First Reported
2010-12-31
Previous Quarter
96 M
Current Value
98.7 M
Quarterly Volatility
48.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check 2Seventy Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 2Seventy Bio's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 12.4 M or Depreciation And Amortization of 10.7 M, as well as many indicators such as Price To Sales Ratio of 5.54, Dividend Yield of 0.0 or PTB Ratio of 0.69. 2Seventy financial statements analysis is a perfect complement when working with 2Seventy Bio Valuation or Volatility modules.
  
Check out the analysis of 2Seventy Bio Correlation against competitors.
For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.

Latest 2Seventy Bio's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of 2Seventy Bio over the last few years. Gross profit is a required income statement account that reflects total revenue of 2Seventy Bio minus its cost of goods sold. It is profit before 2Seventy Bio operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. 2Seventy Bio's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in 2Seventy Bio's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (90.73 M)10 Years Trend
Slightly volatile
   Gross Profit   
41.3242.52.065.383.596.098.7487%-79%26%28%15%3%100%
       Timeline  

2Seventy Gross Profit Regression Statistics

Arithmetic Mean72,672,083
Geometric Mean64,934,044
Coefficient Of Variation66.43
Mean Deviation28,777,375
Median53,694,000
Standard Deviation48,279,502
Sample Variance2330.9T
Range201.4M
R-Value0.37
Mean Square Error2155T
R-Squared0.14
Significance0.16
Slope3,754,787
Total Sum of Squares34963.7T

2Seventy Gross Profit History

202598.7 M
202496 M
202383.5 M
202265.3 M
202152 M
2020242.7 M
201941.3 M

Other Fundumenentals of 2Seventy Bio

2Seventy Bio Gross Profit component correlations

1.00.980.27-0.97-0.860.94-0.780.971.00.990.960.51-0.45-0.92-0.980.72
1.00.990.25-0.97-0.890.95-0.770.941.00.990.970.56-0.51-0.9-0.980.74
0.980.990.31-0.96-0.90.92-0.760.910.990.990.970.61-0.55-0.9-0.970.8
0.270.250.31-0.43-0.190.11-0.670.310.250.290.390.32-0.34-0.53-0.420.58
-0.97-0.97-0.96-0.430.9-0.890.87-0.92-0.97-0.95-0.97-0.650.570.90.98-0.75
-0.86-0.89-0.9-0.190.9-0.890.75-0.71-0.89-0.87-0.9-0.830.80.680.88-0.73
0.940.950.920.11-0.89-0.89-0.740.850.950.950.950.5-0.59-0.82-0.930.74
-0.78-0.77-0.76-0.670.870.75-0.74-0.77-0.77-0.77-0.87-0.590.660.810.86-0.79
0.970.940.910.31-0.92-0.710.85-0.770.940.920.90.36-0.27-0.92-0.920.61
1.01.00.990.25-0.97-0.890.95-0.770.940.990.970.56-0.51-0.9-0.980.74
0.990.990.990.29-0.95-0.870.95-0.770.920.990.980.53-0.52-0.92-0.980.8
0.960.970.970.39-0.97-0.90.95-0.870.90.970.980.59-0.63-0.92-0.990.83
0.510.560.610.32-0.65-0.830.5-0.590.360.560.530.59-0.85-0.33-0.560.58
-0.45-0.51-0.55-0.340.570.8-0.590.66-0.27-0.51-0.52-0.63-0.850.360.56-0.75
-0.92-0.9-0.9-0.530.90.68-0.820.81-0.92-0.9-0.92-0.92-0.330.360.95-0.78
-0.98-0.98-0.97-0.420.980.88-0.930.86-0.92-0.98-0.98-0.99-0.560.560.95-0.8
0.720.740.80.58-0.75-0.730.74-0.790.610.740.80.830.58-0.75-0.78-0.8
Click cells to compare fundamentals

About 2Seventy Bio Financial Statements

2Seventy Bio shareholders use historical fundamental indicators, such as Gross Profit, to determine how well the company is positioned to perform in the future. Although 2Seventy Bio investors may analyze each financial statement separately, they are all interrelated. The changes in 2Seventy Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on 2Seventy Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Gross Profit96 M98.7 M
Gross Profit Margin 0.83  0.96 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for 2Seventy Stock Analysis

When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.

Trending Assets

DAWN
Day One Biopharmaceu
8.04  0.00  0.00 
KZR
Kezar Life Sciences
5.34  -0.3  -5.32 
ZNTL
Zentalis Pharmaceuticals
1.87  -0.11  -5.56 
THRX
Theseus Pharmaceuticals
0.00  0.00  0.00 
PLRX
Pliant Therapeutics
1.47  -0.02  -1.34 
ASND
Ascendis Pharma AS
158.13  -2.91  -1.81 
INZY
Inozyme Pharma
0.97  -0.04  -4.27 
REPL
Replimune Group
10.23  -0.46  -4.3 
PBYI
Puma Biotechnology
3.19  -0.06  -1.85 
CRNX
Crinetics Pharmaceuticals
33.41  -1.66  -4.73 
RCUS
Arcus Biosciences
8.07  -1.05  -11.51 
CGEM
Cullinan Oncology LLC
8.15  -0.15  -1.81 
RLAY
Relay Therapeutics
2.87  -0.09  -3.04 
DICE
Dice Molecules Holdings
0.00  0.00  0.00 
KDNY
Chinook Therapeutics
0.00  0.00  0.00 
PHAT
Phathom Pharmaceuticals
6.39  -0.16  -2.44 
IOVA
Iovance Biotherapeutics
3.48  -0.15  -4.13 
ICPT
Intercept Pharmaceuticals
0.00  0.00  0.00 
MRSN
Mersana Therapeutics
0.42  -0.03  -7.69 
PTGX
Protagonist Therapeutics
49.65  -1.4  -2.74 
News Freq…Investor S…